Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marius, Distler"'
Autor:
Ujjwal M. Mahajan, Bettina Oehrle, Simon Sirtl, Ahmed Alnatsha, Elisabetta Goni, Ivonne Regel, Georg Beyer, Marlies Vornhülz, Jakob Vielhauer, Ansgar Chromik, Markus Bahra, Fritz Klein, Waldemar Uhl, Tim Fahlbusch, Marius Distler, Jürgen Weitz, Robert Grützmann, Christian Pilarsky, Frank Ulrich Weiss, M. Gordian Adam, John P. Neoptolemos, Holger Kalthoff, Roland Rad, Nicole Christiansen, Bianca Bethan, Beate Kamlage, Markus M. Lerch, Julia Mayerle
Publikováno v:
Gastroenterology. 163:1407-1422
Pancreatic ductal adenocarcinoma cancer (PDAC) is a highly lethal malignancy requiring efficient detection when the primary tumor is still resectable. We previously developed the MxPancreasScore comprising 9 analytes and serum carbohydrate antigen 19
Publikováno v:
Zentralblatt fur Chirurgie. 147(2)
Ampullary carcinoma belongs to the cluster of periampullary cancers and is a rare, but increasing form of gastrointestinal malignancy. Due to the location of the tumour, occurrence of biliary obstruction is common. Symptoms due to the compression of
Autor:
Alexander Hennig, Franziska Baenke, Anna Klimova, Stephan Drukewitz, Beatrix Jahnke, Sascha Brückmann, Ramona Secci, Christof Winter, Tim Schmäche, Therese Seidlitz, Jean‐Paul Bereuter, Heike Polster, Lisa Eckhardt, Sidney A Schneider, Stefan Brückner, Renate Schmelz, Jana Babatz, Christoph Kahlert, Marius Distler, Jochen Hampe, Maximilian Reichert, Sebastian Zeißig, Gunnar Folprecht, Jürgen Weitz, Daniela Aust, Thilo Welsch, Daniel E Stange
Publikováno v:
The Journal of pathologyReferences. 257(5)
Drug combination therapies for cancer treatment show high efficacy but often induce severe side effects, resulting in dose or cycle number reduction. We investigated the impact of neoadjuvant chemotherapy (neoCTx) adaptions on treatment outcome in 59
Autor:
Max Heiduk, Christoph Kahlert, Thilo Welsch, Christoph Reissfelder, Lena Seifert, Charlotte Reiche, Adrian M. Seifert, Daniela Aust, George Miller, Marius Distler, Anna Tannert, Stephanie Baier, Ann-Christin Meinecke, Jürgen Weitz, Janusz von Renesse
Publikováno v:
Oncogene
Pancreatic ductal adenocarcinoma (PDAC) responds poorly to checkpoint blockade, such as anti-CTLA-4 and anti-PD-1. Galectin-9, a β-galactoside-binding lectin, promotes immune suppression through T-cell inhibition, and programming of tolerogenic macr
Autor:
Louisa Bolm, Tobias Keck, Thilo Welsch, Richard Stimpel, Robert Grützmann, Ulrich F. Wellner, Jürgen Weitz, Susanne Merkel, Daniela Aust, Christian Teske, Marius Distler
Publikováno v:
Langenbeck's Archives of Surgery
Background The present study aimed to examine the impact of microscopically tumour-infiltrated resection margins (R1) in pancreatic ductal adenocarcinoma (PDAC) patients with advanced lymphonodular metastasis (pN1–pN2) on overall survival (OS). Met
Autor:
Markus M. Lerch, Philipp Schatz, Robert Grützmann, Bodo Schniewind, Claus-Dieter Heidecke, Holger Kalthoff, F. Ulrich Weiss, Christian Pilarsky, Julia Mayerle, Ujjwal M. Mahajan, Beate Kamlage, Erik Peter, Jonas A. Scheiber, Sandra González Maldonado, Regina Reszka, Marius Distler
Publikováno v:
Gut
ObjectiveCurrent non-invasive diagnostic tests can distinguish between pancreatic cancer (pancreatic ductal adenocarcinoma (PDAC)) and chronic pancreatitis (CP) in only about two thirds of patients. We have searched for blood-derived metabolite bioma
Autor:
Hans-Detlev Saeger, Sebastian Hempel, Franz Mierke, Daniela Aust, Marius Distler, Jürgen Weitz, Thilo Welsch
Publikováno v:
Annals of surgical oncology. 23(Suppl 5)
The present study aims to evaluate the long-term outcome and metastatic pattern of patients who underwent resection of a pancreatic ductal adenocarcinoma (PDAC) with portal or superior mesenteric vein (PV/SMV) resection. Patients who underwent a part
Autor:
Stephan Kersting, A. Bunk, Robert Grützmann, Marius Distler, Florina Kersting, R. Konopke, Andreas Volk, Hans Detlev Saeger, Hendrik Bergert
Publikováno v:
Gastroenterology. 137:1903-1911
Background & Aims Preoperative differential diagnosis of pancreatic ductal adenocarcinoma (PDAC) and focal masses in patients with chronic pancreatitis (CP) can be challenging. There are fine differences in the vascularization of these lesions; ultra
Autor:
M. Schröder, Marius Distler, Hans-Detlev Saeger, Gihan Dawelbait, Eleftherios P. Diamandis, Hennig M, Diana Wehrum, Robert Grützmann, Constantina Petraki, Felix Rückert, Axel Denz, Holger Kalthoff, Christian Pilarsky
Publikováno v:
British Journal of Cancer
Kallikreins play an important role in tumour microenvironment and as cancer biomarkers in different cancer entities. Previous studies suggested an upregulation of KLK10 and KLK6 in pancreatic ductal adenocarcinoma (PDAC). Therefore, we evaluated the
Publikováno v:
International Journal of Surgery. (10):1067-1072
Background The prognosis for patients with ductal adenocarcinoma of the pancreas (PDAC) remains poor even after curative resection. Carbohydrate antigen 19-9 (CA 19-9) and the carcinoembryonic antigen (CEA) are the most widely used serum-based tumor